RSV Prevention in All Infants: Which Is the Most Preferable Strategy?
Respiratory syncytial virus (RSV) causes a spectrum of respiratory illnesses in infants and young children that may lead to hospitalizations and a substantial number of outpatient visits, which result in a huge economic and healthcare burden. Most hospitalizations happen in otherwise healthy infants...
Main Authors: | Susanna Esposito, Bahaa Abu Raya, Eugenio Baraldi, Katie Flanagan, Federico Martinon Torres, Maria Tsolia, Stefan Zielen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.880368/full |
Similar Items
-
Preventing Respiratory Syncytial Virus in Children in France: A Narrative Review of the Importance of a Reinforced Partnership Between Parents, Healthcare Professionals, and Public Health Authorities
by: Didier Pinquier, et al.
Published: (2022-12-01) -
RSV Disease Threat and Innovative Prevention Methods in Health Protection: A Review
by: Paulina Dąbrowska, et al.
Published: (2024-02-01) -
The efficacy and safety of nirsevimab for the prevention of RSV infection among infants: A systematic review and meta-analysis
by: Maria Wilma R. Turalde-Mapili, et al.
Published: (2023-04-01) -
The Modification of the Illumina<sup>®</sup> CovidSeq™ Workflow for RSV Genomic Surveillance: The Genetic Variability of RSV during the 2022–2023 Season in Northwest Spain
by: Carlos Davina-Nunez, et al.
Published: (2023-11-01) -
Epitope-Specific Serological Assays for RSV: Conformation Matters
by: Emily Phung, et al.
Published: (2019-02-01)